1. Home
  2. ALXO vs SHOT Comparison

ALXO vs SHOT Comparison

Compare ALXO & SHOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALXO
  • SHOT
  • Stock Information
  • Founded
  • ALXO 2015
  • SHOT 2018
  • Country
  • ALXO United States
  • SHOT United States
  • Employees
  • ALXO N/A
  • SHOT N/A
  • Industry
  • ALXO Biotechnology: Pharmaceutical Preparations
  • SHOT Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALXO Health Care
  • SHOT Health Care
  • Exchange
  • ALXO Nasdaq
  • SHOT Nasdaq
  • Market Cap
  • ALXO 24.0M
  • SHOT 30.4M
  • IPO Year
  • ALXO 2020
  • SHOT 2020
  • Fundamental
  • Price
  • ALXO $0.56
  • SHOT $0.26
  • Analyst Decision
  • ALXO Strong Buy
  • SHOT
  • Analyst Count
  • ALXO 6
  • SHOT 0
  • Target Price
  • ALXO $3.30
  • SHOT N/A
  • AVG Volume (30 Days)
  • ALXO 456.6K
  • SHOT 2.0M
  • Earning Date
  • ALXO 05-08-2025
  • SHOT 05-15-2025
  • Dividend Yield
  • ALXO N/A
  • SHOT N/A
  • EPS Growth
  • ALXO N/A
  • SHOT N/A
  • EPS
  • ALXO N/A
  • SHOT N/A
  • Revenue
  • ALXO N/A
  • SHOT $573,336.00
  • Revenue This Year
  • ALXO N/A
  • SHOT N/A
  • Revenue Next Year
  • ALXO N/A
  • SHOT N/A
  • P/E Ratio
  • ALXO N/A
  • SHOT N/A
  • Revenue Growth
  • ALXO N/A
  • SHOT 69.32
  • 52 Week Low
  • ALXO $0.41
  • SHOT $0.25
  • 52 Week High
  • ALXO $10.97
  • SHOT $1.77
  • Technical
  • Relative Strength Index (RSI)
  • ALXO 59.08
  • SHOT 24.82
  • Support Level
  • ALXO $0.44
  • SHOT $0.26
  • Resistance Level
  • ALXO $0.48
  • SHOT $0.45
  • Average True Range (ATR)
  • ALXO 0.05
  • SHOT 0.05
  • MACD
  • ALXO 0.02
  • SHOT -0.02
  • Stochastic Oscillator
  • ALXO 99.16
  • SHOT 3.74

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

About SHOT Safety Shot Inc.

Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.

Share on Social Networks: